When 4-IPP was developed as a more potent inhibitor of MIF compared to its prototypes, its efficacy was demonstrated by strongly inhibiting lung adenocarcinoma cell migration and proliferation [24]. This evidence concerns the gene MIF and lung adenocarcinoma.